Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum: Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.
Journal: JCO precision oncology
Published: July 16, 2026
Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation.
Journal: Cancers
Published: April 09, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.
Journal: JCO precision oncology
Published: February 13, 2026
Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 05, 2026
ctDNA Dynamics Identifies Pseudoprogression in a Metastatic Melanoma Patient Treated With Nivolumab/Relatlimab.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 14, 2025
BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: December 03, 2024
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.
Journal: Scientific reports
Published: August 03, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026